Aspartato di Arginina: Review su farmacocinetica, farmacodinamica ed efficacia terapeutica nel trattamento degli stati astenici

Translated title of the contribution: Arginine Aspartate: Review on pharmacokinetics, pharmacodynamics and therapeutic efficacy in the treatment of asthenic conditions

G. Dell'Erba, F. Di Girolamo, T. Losi, C. D. Vizza

Research output: Contribution to journalArticle

Abstract

After a description of the asthenic syndrome and some observations on its frequency in the population, the authors describe the rationale for the therapeutical use of different categories of substances with antiasthenic properties. Among these, special attention is given to Arginine Aspartate, a dipeptide very used in the treatment of mental and physical asthenia. At first, the pharmacokinetic characteristics of the substance, studied in trials in animals and in healthy volunteers, are reviewed. Afterwards, some experimental data on the pharmacodynamics of Arginine Aspartate are presented, selecting these documenting the biochemical mechanism of action supporting the antiasthenic effect of the substance. The last part of the review is devoted to the clinical documentation and has been based on the most recent studies carried out on controlled experimental models, randomized, double blind and with acceptable statistical evaluation of results. On the basis of the data examined and of personal experiences, the conclusion is drawn that Arginine Aspartate has a clear therapeutic properties in the treatment of asthenic conditions.

Original languageItalian
Pages (from-to)155-163
Number of pages9
JournalGazzetta Medica Italiana Archivio per le Scienze Mediche
Volume160
Issue number4-5
Publication statusPublished - Oct 2001

Fingerprint

Pharmacokinetics
Asthenia
Dipeptides
Documentation
Healthy Volunteers
Theoretical Models
Therapeutics
Population
arginine aspartate

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Aspartato di Arginina : Review su farmacocinetica, farmacodinamica ed efficacia terapeutica nel trattamento degli stati astenici. / Dell'Erba, G.; Di Girolamo, F.; Losi, T.; Vizza, C. D.

In: Gazzetta Medica Italiana Archivio per le Scienze Mediche, Vol. 160, No. 4-5, 10.2001, p. 155-163.

Research output: Contribution to journalArticle

@article{0d304ce1d5b843cdb8ef752ff717eca9,
title = "Aspartato di Arginina: Review su farmacocinetica, farmacodinamica ed efficacia terapeutica nel trattamento degli stati astenici",
abstract = "After a description of the asthenic syndrome and some observations on its frequency in the population, the authors describe the rationale for the therapeutical use of different categories of substances with antiasthenic properties. Among these, special attention is given to Arginine Aspartate, a dipeptide very used in the treatment of mental and physical asthenia. At first, the pharmacokinetic characteristics of the substance, studied in trials in animals and in healthy volunteers, are reviewed. Afterwards, some experimental data on the pharmacodynamics of Arginine Aspartate are presented, selecting these documenting the biochemical mechanism of action supporting the antiasthenic effect of the substance. The last part of the review is devoted to the clinical documentation and has been based on the most recent studies carried out on controlled experimental models, randomized, double blind and with acceptable statistical evaluation of results. On the basis of the data examined and of personal experiences, the conclusion is drawn that Arginine Aspartate has a clear therapeutic properties in the treatment of asthenic conditions.",
keywords = "Amino acids, pharmacology, Amino acids, therapeutical use, Asthenia, drug therapy",
author = "G. Dell'Erba and {Di Girolamo}, F. and T. Losi and Vizza, {C. D.}",
year = "2001",
month = "10",
language = "Italian",
volume = "160",
pages = "155--163",
journal = "Gazzetta Medica Italiana Archivio per le Scienze Mediche",
issn = "0393-3660",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "4-5",

}

TY - JOUR

T1 - Aspartato di Arginina

T2 - Review su farmacocinetica, farmacodinamica ed efficacia terapeutica nel trattamento degli stati astenici

AU - Dell'Erba, G.

AU - Di Girolamo, F.

AU - Losi, T.

AU - Vizza, C. D.

PY - 2001/10

Y1 - 2001/10

N2 - After a description of the asthenic syndrome and some observations on its frequency in the population, the authors describe the rationale for the therapeutical use of different categories of substances with antiasthenic properties. Among these, special attention is given to Arginine Aspartate, a dipeptide very used in the treatment of mental and physical asthenia. At first, the pharmacokinetic characteristics of the substance, studied in trials in animals and in healthy volunteers, are reviewed. Afterwards, some experimental data on the pharmacodynamics of Arginine Aspartate are presented, selecting these documenting the biochemical mechanism of action supporting the antiasthenic effect of the substance. The last part of the review is devoted to the clinical documentation and has been based on the most recent studies carried out on controlled experimental models, randomized, double blind and with acceptable statistical evaluation of results. On the basis of the data examined and of personal experiences, the conclusion is drawn that Arginine Aspartate has a clear therapeutic properties in the treatment of asthenic conditions.

AB - After a description of the asthenic syndrome and some observations on its frequency in the population, the authors describe the rationale for the therapeutical use of different categories of substances with antiasthenic properties. Among these, special attention is given to Arginine Aspartate, a dipeptide very used in the treatment of mental and physical asthenia. At first, the pharmacokinetic characteristics of the substance, studied in trials in animals and in healthy volunteers, are reviewed. Afterwards, some experimental data on the pharmacodynamics of Arginine Aspartate are presented, selecting these documenting the biochemical mechanism of action supporting the antiasthenic effect of the substance. The last part of the review is devoted to the clinical documentation and has been based on the most recent studies carried out on controlled experimental models, randomized, double blind and with acceptable statistical evaluation of results. On the basis of the data examined and of personal experiences, the conclusion is drawn that Arginine Aspartate has a clear therapeutic properties in the treatment of asthenic conditions.

KW - Amino acids, pharmacology

KW - Amino acids, therapeutical use

KW - Asthenia, drug therapy

UR - http://www.scopus.com/inward/record.url?scp=0035732561&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035732561&partnerID=8YFLogxK

M3 - Articolo

AN - SCOPUS:0035732561

VL - 160

SP - 155

EP - 163

JO - Gazzetta Medica Italiana Archivio per le Scienze Mediche

JF - Gazzetta Medica Italiana Archivio per le Scienze Mediche

SN - 0393-3660

IS - 4-5

ER -